Our current newsletter features a great article by Oxeon co-founder & Senior Associate Schuyler Yost discussing behavioral health integration, as well as an insightful interview between Associate Liam Gallagher and Bryan Sivak, former CTO of the U.S. Department of Health and Human Services. Hope you enjoy!
Oxeon is pleased to announce the placement of Jon Hanesian as Vice President of Partner Development at Evolent Health. Jon joins from Booz & Company, where he was a Senior Healthcare Consultant. Evolent Health offers the first provider-led, fully integrated platform for population and health plan management to leading health systems. Evolent Health is funded by UPMC Health Plan, The Advisory Board Company and TPG Growth.
Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics, No. 3 in rheumatology and No. 7 in geriatrics by U.S. News & World Report, and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center three consecutive times.
Oxeon is pleased to announce the placement of Brian Drozdowicz as Executive Vice President of Product Management at Verisk Health. Brian joins from Caradigm, where he served as Senior Vice President & GM, Population Health and Analytics. Verisk Health is transforming the business of healthcare by providing data services, analytics, and advanced technologies that answer the industry’s most complex challenges. Verisk Health is a subsidiary of Verisk Analytics.
Oxeon is pleased to announce the placement of Dr. Marc-David Munk as Vice President of Accountable Care at Iora Health. Dr. Munk joins from Reliant Medical Group, where he served as Chief Medical Officer. Iora is building a new model of primary health care delivery ground up to ensure improved customer service, better health outcomes and dramatically lower overall healthcare costs. Iora is funded by Flare Capital Partners, Rice Management Company, GE Ventures, Khosla Ventures, Fidelity Biosciences, Polaris Partners, .406 Ventures and Tony Hsieh, among others. Iora Health is a portfolio investment of Oxeon Investments LLC.
Congratulations to Quartet Health and their newest Board member, Patrick Kennedy! Kennedy joins Quartet’s Board of Directors as an independent member. The Board currently includes Chief Executive Officer Arun Gupta, Chairman Steve Shulman, Annie Lamont of Oak HC/FT, and Board Observer Carl Byers of Fidelity Biosciences.